Journal Article Summary
The article investigates the effects of daily aspirin use on mortality and liver-related events in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), a condition that has been increasingly recognized as a significant health issue. Previously known as non-alcoholic fatty liver disease (NAFLD), MASLD is linked to metabolic disorders such as obesity and diabetes. Understanding the impact of aspirin, which has shown some promise in reducing liver cancer risk in other liver diseases, is crucial for determining effective management strategies for MASLD patients.
In this study, researchers analyzed data from over 48,000 MASLD patients from multiple medical institutions between 2008 and 2020, focusing on those who used aspirin compared to those who did not. After applying strict criteria to ensure comparable groups, they found that aspirin use did not significantly reduce overall mortality, liver-related events, or the incidence of liver cancer over a three-year period. While there was a trend suggesting potential benefits, such as lower liver-related mortality and cancer incidence, these did not reach statistical significance, and no increased risk of major bleeding was observed among aspirin users.
The study has several limitations, including its retrospective design and the potential for unmeasured confounding factors that could influence outcomes. Patients and caregivers should discuss these findings with healthcare professionals, especially regarding the use of aspirin for MASLD management. While the study suggests that aspirin alone may not be beneficial for MASLD patients, further research is needed to explore its long-term effects and potential benefits when combined with other therapies.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Huang Chien-Hao, Wang Chun-Li, Wu Victor Chien-Chia, Hsieh Yi-Chung, Wu Chia-Ling, Zeng Z-Fan, Huang Yu-Tung, Hsu Chao-Wei, et al.. Association of aspirin use alone with mortality and liver-related events in MASLD: a multi-institutional three-year study. Annals of Medicine 2025. DOI: 10.1080/07853890.2025.2573146. PMID: 41103259. PMCID: PMC12536622.
Featured Pill Pals Product
1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over --- Generic For Bayer Low Dose --- Time Cap Labs --- Over The Counter
1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over — Generic For Bayer Low Dose — Time Cap Labs — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
